Spirulina platensis soluble polysaccharide as well as extraction method and application thereof

By optimizing the extraction process of the spirulina polysaccharide, the problem of insufficient research on its anti-tumor activity was solved, the effect of effectively inhibiting solid tumor growth in the body was achieved, and new natural drug possibilities were provided for cancer prevention and treatment.

CN118930677APending Publication Date: 2024-11-12BEIJING FORESTRY UNIVERSITY
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411203938.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art studies on the anti-tumor activity of the blunt-topped spirulina polysaccharide are relatively limited, especially in the inhibition of solid tumor growth in the body, and the extraction process efficiency and safety need to be improved.

Method used

The soluble polysaccharide of spirulina is extracted by hot alkali leaching, centrifugation, deprotein treatment and dialysis. The process parameters are optimized to improve extraction efficiency and biosafety, and its resistance is verified through CCK-8 evaluation and tumor-bearing mouse model. Tumor activity.

Benefits of technology

The obtained blunt-topped Spirulina soluble polysaccharide has significant anti-tumor effect, can effectively inhibit the growth of various tumor cells, significantly inhibit the growth of solid tumors in the body, and has good biosafety, providing potential applications for cancer prevention and treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930677A_ABST
    Figure CN118930677A_ABST
Patent Text Reader

Abstract

The invention provides spirulina platensis soluble polysaccharide as well as an extraction method and application thereof, and relates to the technical field of spirulina polysaccharide extraction. According to the invention, spirulina platensis powder is taken as a raw material, and the extraction process is optimized by using a response surface method, so that the spirulina platensis soluble polysaccharide is obtained. The yield of the spirulina platensis soluble polysaccharide obtained through the extraction method is 7% or above. According to the application disclosed by the invention, the growth and killing effects of the soluble polysaccharide on tumor cells are evaluated through CCK-8, and a result shows that the soluble polysaccharide can inhibit the growth of various tumor cells such as 4T1, HeLa and HCT116. The in-vivo anti-tumor activity of the soluble polysaccharide is evaluated by establishing a 4T1 tumor-bearing mouse model, and it is shown that WSP-TCA can effectively inhibit growth of solid tumors in vivo, and the anti-tumor effect is remarkable. The spirulina platensis soluble polysaccharide extracted by the invention is a natural substance with good biological safety and anti-tumor activity, and provides possibility for application of the spirulina platensis soluble polysaccharide in the fields of cancer prevention and treatment and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of spirulina polysaccharide extraction, and specifically relates to a soluble polysaccharide of Spirulina platensis and an extraction method and application thereof. Background Art

[0002] Spirulina is a plant that uses sunlight as energy to grow on its own. It is rich in a variety of nutrients, such as polysaccharides, proteins, trace elements and vitamins. There are more than 40 species of Spirulina. Currently, my country has approved two species for industrial cultivation, namely, Spirulina platensis and Spirulina maxima. Spirulina platensis has a short growth cycle and strong adaptability, and is an algae with great potential.

[0003] Spirulina platensis is abundant in the north and south of my country, and has balanced nutrition, rich in protein, polysaccharides, natural pigments, etc. Spirulina platensis polysaccharides can widely participate in various life activities of cells, and have anti-tumor activity and immunomodulatory activity. At present, the activity research of Spirulina platensis polysaccharides mainly focuses on its immune activity, while its anti-tumor activity needs to be further studied. Summary of the invention

[0004] In view of this, the purpose of the present invention is to provide a soluble polysaccharide of Spirulina platensis and an extraction method and application thereof. The soluble polysaccharide of Spirulina platensis extracted by the present invention has good biosafety, can effectively inhibit the growth of solid tumors in vivo, and has a significant anti-tumor effect.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides a method for extracting soluble polysaccharides from Spirulina platensis, comprising the following steps:

[0007] The Spirulina platensis powder is subjected to hot alkali extraction to obtain an extract;

[0008] The extract is centrifuged to collect the supernatant and the precipitate; the precipitate is subjected to hot alkali leaching and centrifugation again to obtain the supernatant, and the supernatants are combined to obtain the platensis liquid;

[0009] Add 25% trichloroacetic acid to the above Spirulina platensis solution for deproteinization and then dialyze to obtain a dialysate;

[0010] The dialyzate is subjected to alcohol precipitation and freeze-drying to obtain the soluble polysaccharide of Spirulina platensis.

[0011] Preferably, the conditions for the hot alkali leaching are to adjust the solution pH to 10-10.5 and heat the solution in a water bath at 80-90° C. for 3.5-4.5 hours.

[0012] Preferably, the centrifugation condition is 4000-6000 r / min for 10-20 min.

[0013] Preferably, the volume mass ratio of the 25% trichloroacetic acid to the Spirulina platensis powder is 0.5-0.8:1.

[0014] Preferably, the dialysis condition is to use a dialysis bag with a pore size of 3kD-4kD for 40-50h.

[0015] Preferably, the ethanol concentration of the alcohol precipitation is 90-95%.

[0016] The invention provides a soluble polysaccharide of Spirulina platensis obtained by the extraction method.

[0017] The invention provides an application of the soluble polysaccharide of Spirulina platensis in preparing an antioxidant.

[0018] The invention provides an application of the soluble polysaccharide of Spirulina platensis in preparing anti-tumor drugs.

[0019] Preferably, the tumor comprises one of breast cancer, cervical cancer or colon cancer.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] The present invention uses Spirulina platensis powder as a raw material, uses the response surface methodology to optimize the extraction process, and obtains soluble polysaccharides of Spirulina platensis. The extraction method of the present invention obtains a yield of soluble polysaccharides of Spirulina platensis (WSP-TCA) of more than 7%. The present invention evaluates the growth and killing effects of soluble polysaccharides on tumor cells by CCK-8, and the results show that it can inhibit the growth of multiple tumor cells such as 4T1, HeLa, and HCT116. The present invention evaluates the in vivo anti-tumor activity of soluble polysaccharides by establishing a 4T1 tumor-bearing mouse model, indicating that WSP-TCA can effectively inhibit the growth of solid tumors in vivo, and the anti-tumor effect is significant. The soluble polysaccharides of Spirulina platensis obtained by the present invention are natural substances with good biosafety and anti-tumor activity, which provides possibilities for their application in the fields of cancer prevention and treatment. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 The effect of extraction temperature on the yield of WSP-TCA;

[0023] Figure 2 The effect of heating time on the yield of WSP-TCA;

[0024] Figure 3 The effect of pH on the yield of WSP-TCA;

[0025] Figure 4The effect of the interaction between pH and time on the yield of WSP-TCA;

[0026] Figure 5 The effect of the interaction between pH and temperature on the yield of WSP-TCA;

[0027] Figure 6 The effect of the interaction between temperature and time on the yield of WSP-TCA;

[0028] Figure 7 The ion chromatograms of monosaccharide standard and WSP-TCA, A is the ion chromatogram of monosaccharide standard, and B is the ion chromatogram of WSP-TCA;

[0029] Figure 8 is the molecular weight distribution diagram of WSP-TCA;

[0030] Fig. 9 It is the infrared spectrum of WSP-TCA;

[0031] Fig.10 For WSP-TCA 1 H NMR spectrum;

[0032] Fig.11 The effect of WSP-TCA on DPPH free radical scavenging rate;

[0033] Fig.12 The effect of WSP-TCA on the scavenging rate of hydroxyl radicals;

[0034] Fig.13 is the effect of WSP-TCA on the total reducing power;

[0035] Fig.14 The effect of WSP-TCA on 4T1 cell viability;

[0036] Fig.15 The effect of WSP-TCA on HeLa cell viability;

[0037] Fig.16 The effect of WSP-TCA on HCT116 cell viability;

[0038] Fig.17 The effect of WSP-TCA at different concentrations on HUVEC cell viability;

[0039] Fig.18 The effect of WSP-TCA at different concentrations on the migration ability of tumor cells;

[0040] Fig.19 The effect of WSP-TCA on the wound healing rate of 4T1 cells;

[0041] Fig. 20 The effect of WSP-TCA on the wound healing rate of HeLa cells;

[0042] Fig.21 The effect of WSP-TCA at different concentrations on the production of reactive oxygen species in 4T1 cells. The scale bar in the figure is 75 μm.

[0043] Fig. 22 The effect of WSP-TCA at different concentrations on the generation of reactive oxygen species in HUVEC cells. The scale bar in the figure is 50 μm.

[0044] Fig.23 The weight results of mice in the control model group and the experimental group;

[0045] Fig.24 The in vitro morphology of tumor tissues in tumor-bearing mice before dissection;

[0046] Fig.25 The results of solid tumor volume of mice in the control model group and experimental group;

[0047] Fig.26 The paraffin sections of tumor tissues of mice in the control model group and the experimental group. The left picture is the paraffin sections of tumor tissues of mice in the control group, and the right picture is the paraffin sections of tumor tissues of mice in the experimental group. The scale bar in the figure is 100μm.

[0048] Fig. 27 The left picture shows the paraffin sections of spleen tissue of mice in the control group and the experimental group. The right picture shows the paraffin sections of spleen tissue of mice in the experimental group. The scale bar in the picture is 40 μm.

[0049] Fig.28 The paraffin sections of the heart tissue of the mice in the control model group and the experimental group. The left picture is the paraffin section of the heart tissue of the mice in the control group, and the right picture is the paraffin section of the heart tissue of the mice in the experimental group. The scale bar in the figure is 40μm.

[0050] Fig.29 The paraffin sections of liver tissues of mice in the control model group and the experimental group. The left picture is the paraffin sections of liver tissues of mice in the control group, and the right picture is the paraffin sections of liver tissues of mice in the experimental group. The scale bar in the figure is 40μm.

[0051] Fig.30 The paraffin sections of the lung tissues of mice in the control model group and the experimental group. The left picture is the paraffin sections of the lung tissues of mice in the control group, and the right picture is the paraffin sections of the lung tissues of mice in the experimental group. The scale bar in the figure is 40μm.

[0052] Fig.31 These are paraffin sections of kidney tissue of mice in the control model group and the experimental group. The left picture is the paraffin section of kidney tissue of mice in the control group, and the right picture is the paraffin section of kidney tissue of mice in the experimental group. The scale bar in the figure is 40μm. DETAILED DESCRIPTION

[0053] The present invention provides a method for extracting soluble polysaccharides from Spirulina platensis, comprising the following steps:

[0054] The Spirulina platensis powder is subjected to hot alkali extraction to obtain an extract;

[0055] The extract is centrifuged to obtain a supernatant and a precipitate; the precipitate is extracted with hot alkali again and centrifuged to obtain a supernatant, and the supernatants are combined to obtain a platen Spirulina liquid;

[0056] Add 25% trichloroacetic acid to the above Spirulina platensis solution for deproteinization and then dialyze to obtain a dialysate;

[0057] The dialyzate is subjected to alcohol precipitation and freeze-drying to obtain the soluble polysaccharide of Spirulina platensis.

[0058] In the present invention, the Spirulina platensis powder can be purchased through conventional channels. In a specific embodiment of the present invention, the Spirulina platensis powder (dry powder) is purchased from Bosheng Microalgae (Beijing) Technology Co., Ltd.

[0059] In the present invention, the platensis Spirulina powder is preferably subjected to hot alkali extraction to obtain an extract, and the specific steps are preferably as follows: weigh the platensis Spirulina powder and add deionized water in a mass volume ratio of 1:8-12, stir evenly, adjust the pH to 10-10.5 with an alkaline solution, and heat and extract in a water bath at 80-90°C for 3.5-4.5h to obtain an extract. In the present invention, the alkaline solution is preferably NaOH. The present invention does not specifically limit the stirring, and conventional stirring methods in the art can be used. In a specific embodiment of the present invention, stirring is preferably performed on a magnetic stirrer. In the present invention, the conditions for hot alkali extraction are more preferably to adjust the pH to 10.1 with an alkaline solution, and heat in a water bath at 82°C for 4h to obtain an extract.

[0060] In the present invention, the extract obtained above is preferably centrifuged at 4000r / min for 10-20min, the supernatant and the precipitate are collected, the precipitate is subjected to the above hot alkali extraction step again to obtain the extract, centrifuged, and the supernatant is collected; the two supernatants are combined to obtain the platensis liquid. In the present invention, the centrifugation time is more preferably 15min.

[0061] In the present invention, the obtained Spirulina platensis liquid is preferably deproteinized using trichloroacetic acid (TCA), and the specific steps are preferably as follows: the pH of the obtained Spirulina platensis liquid is adjusted to 6.8-7.2; 25% trichloroacetic acid is added to precipitate protein overnight, and the supernatant is collected. In the present invention, the volume mass ratio of the 25% trichloroacetic acid to the Spirulina platensis powder is preferably 0.5-0.8:1; more preferably, the volume mass ratio of 25% trichloroacetic acid to the Spirulina platensis powder is 0.6:1. Specifically, the amount of 25% trichloroacetic acid added is (weight of spirulina dry powder × 0.6) mL. In the present invention, HCl is preferably used to adjust the pH of the Spirulina platensis liquid.

[0062] In the present invention, the deproteinized platen Spirulina solution is dialyzed to obtain a dialysate, and the specific steps are preferably as follows: the deproteinized platen Spirulina solution is centrifuged at 6000r / min for 10-20min, the supernatant is taken, and dialyzed for 40-50h using a dialysis bag with a pore size of 3kD-4kD. In the present invention, it is more preferred to dialyze for 48h using a 3.5kD dialysis bag to obtain the dialysate. In the present invention, the dialysis bag can be purchased through conventional channels. In a specific embodiment of the present invention, the dialysis bag is purchased from Biorigin.

[0063] In the present invention, the dialysate is subjected to ethanol precipitation, and the specific steps are preferably as follows: 4-6 volumes of 95% ethanol are added to the dialysate to treat overnight to precipitate polysaccharides, centrifuged at 6000r / min for 10-20min, the precipitate is taken, and the precipitate is washed 2-3 times with acetone. In the present invention, the centrifugation time is more preferably 15min.

[0064] In the present invention, the precipitate obtained by alcohol precipitation is placed in a freeze dryer for freeze drying for 10-15 hours to obtain the soluble polysaccharide of Spirulina platensis. In the present invention, more preferably, the precipitate is placed in a freeze dryer for freeze drying for 12 hours to obtain the soluble polysaccharide of Spirulina platensis.

[0065] The invention also provides a soluble polysaccharide of Spirulina platensis obtained by the extraction method.

[0066] The present invention provides an application of the soluble polysaccharide of Spirulina platensis in the preparation of antioxidants. DPPH free radicals and hydroxyl free radicals are widely considered to be tools for evaluating the free radical scavenging activity of natural antioxidants. The present invention conducts in vitro antioxidant activity assay on soluble polysaccharides and finds that the soluble polysaccharide of Spirulina platensis can effectively scavenge DPPH free radicals and hydroxyl free radicals, and has a strong total reducing power. This indicates that the soluble polysaccharide of Spirulina platensis extracted by the present invention has potential application value in the preparation of antioxidants.

[0067] The present invention provides an application of the soluble polysaccharide of Spirulina platensis in the preparation of anti-tumor drugs. In the present invention, the tumor preferably includes one of breast cancer, cervical cancer or colon cancer. The present invention evaluates the growth and killing effect of soluble polysaccharides on tumor cells by CCK-8, and the results show that it can inhibit the growth of 4T1, HeLa, HCT116 and other tumor cells. The present invention evaluates the in vivo anti-tumor activity of soluble polysaccharides by establishing a 4T1 tumor-bearing mouse model, indicating that WSP-TCA can effectively inhibit the growth of solid tumors in vivo, and the anti-tumor effect is significant. It shows that the soluble polysaccharide of Spirulina platensis extracted by the present invention has broad application prospects in the fields of cancer prevention and treatment.

[0068] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0069] The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are commercially available products unless otherwise specified.

[0070] Example 1

[0071] A method for extracting Spirulina platensis cell wall polysaccharide, the specific steps are as follows:

[0072] (1) Hot alkaline extraction: Weigh 25 g of Spirulina platensis dry powder, add deionized water at a ratio of 1:10 (w / v), stir evenly on a magnetic stirrer, adjust the pH to 10.1 with NaOH, and heat in a water bath at 82°C for 4 h to obtain an extract.

[0073] (2) Algae liquid separation: the extract is centrifuged at 4000 r / min for 15 min to obtain a supernatant and a precipitate; the precipitate is extracted and centrifuged again in step (1) to obtain a supernatant; the supernatants obtained twice are combined to obtain an algae liquid;

[0074] (3) Deproteinization of soluble polysaccharides: The pH of the algae solution in step (2) was adjusted to 7 with HCl; 15 mL of 25% TCA was added to precipitate the protein overnight, and the supernatant was collected.

[0075] (4) Dialysis: The supernatant was centrifuged at 6000 r / min for 15 min, the supernatant was removed and placed in a large-capacity dialysis bag with a pore size of 3.5 kD for 48 h to obtain a dialysate.

[0076] (5) Ethanol precipitation: Add 5 volumes of 95% alcohol to the dialysate obtained in step (4) to treat overnight to precipitate polysaccharides, centrifuge at 6000 r / min for 15 min, take the precipitate, and wash the precipitate with acetone 2-3 times.

[0077] (6) Freeze drying: The precipitate obtained in step (5) is placed in a freeze dryer for 12 hours to obtain soluble polysaccharides of Spirulina platensis.

[0078] Example 2

[0079] The difference from Example 1 is that in step (1), the pH is adjusted to 10. The remaining steps remain unchanged.

[0080] Example 3

[0081] The difference from Example 1 is that in step (1), the pH is adjusted to 10.5. The remaining steps remain unchanged.

[0082] Example 4

[0083] The difference from Example 1 is that the water bath heating temperature in step (1) is 80° C. The remaining steps remain unchanged.

[0084] Example 5

[0085] The difference from Example 1 is that the water bath heating temperature in step (1) is 90° C. The remaining steps remain unchanged.

[0086] Example 6

[0087] The difference from Example 1 is that the extraction time in step (1) is 3.5 h. The other steps remain unchanged.

[0088] Example 7

[0089] The difference from Example 1 is that the extraction time in step (1) is 4.5 h. The remaining steps remain unchanged

[0090] Test Example 1

[0091] Single factor experimental design of TCA deproteinization method

[0092] The soluble polysaccharides of Spirulina platensis were extracted according to the steps of Example 1, and the effects of different extraction temperatures (70, 75, 80, 85, 90°C), extraction times (3, 3.5, 4, 4.5, 5h) and extraction pH (9, 9.5, 10, 10.5, 11) on the content of soluble polysaccharides (WSP-TCA) of Spirulina platensis were studied.

[0093] according to Figure 1 The results showed that when the water bath temperature was in the range of 70-80℃, the WSP-TCA yield increased significantly due to the increase in temperature. After that, the WSP-TCA yield did not change significantly when the temperature was further increased, and it had tended to a stable state. When the water bath temperature was 80℃, the WSP-TCA yield was the largest, reaching 6.87%. Therefore, 80℃ was selected as the central test point of the WSP-TCA extraction temperature.

[0094] according to Figure 2The results showed that when heated for 3-4 hours, the yield of WSP-TCA increased with the increase of temperature. After the heating time exceeded 4.5 hours, the yield of WSP-TCA began to decrease due to the destruction of the structure of polysaccharides by long-term heating, which caused the polysaccharides to degrade. After comprehensive consideration, 3.5 hours was selected as the central test point of WSP-TCA extraction time.

[0095] according to Figure 3 The results showed that at pH 8-10, as the NaOH concentration increased, the cell wall of Spirulina was easily destroyed, which was conducive to the dissolution of polysaccharides, and the WSP-TCA yield showed a gradual increase. However, too high a pH would cause the polysaccharides to hydrolyze and the proteins to denature. Therefore, pH 10 was selected as the central test point of the WSP-TCA extraction pH.

[0096] Under the above conditions, the content of soluble polysaccharides from Spirulina platensis reached 78.36% and the yield was 6.61%.

[0097] Test Example 2

[0098] Plackett-Burman experimental design method was used to screen the influencing factors of TCA deproteinization. Each factor was selected at two levels, low (-1) and high (+1), with a total of 9 experimental combinations.

[0099] Response surface methodology was used to optimize the extraction process parameters of soluble polysaccharides from Spirulina platensis (WSP-TCA). As shown in Table 1, a three-factor three-level model was constructed using the Box-Behnken method using Design Expert 10.0.7 software.

[0100] Table 1 TCA deproteinization method response surface test factors and level design

[0101]

[0102] The experimental study of WSP-TCA extraction method was designed and studied using Design Expert 10.0.7 software, and the results are shown in Table 2. After polynomial regression fitting, variance analysis and significance test, the regression equation of the polysaccharide yield Y for the coding value of each condition was obtained, as shown below:

[0103] Y=6.95+0.6534A+0.0843B+0.4966C-0.0485AB-0.2103AC-0.04573A 2 -0.5741B 2 -0.7088C 2 , R 2 =0.9962.

[0104] Table 2 Response surface analysis experimental design and results

[0105]

[0106]

[0107] As shown in Table 3, the regression coefficient F value of the model is 202.61, P < 0.0001, and the P value of the lack of fit term is 0.0736> 0.05, which is not significant, indicating that the model is extremely significant. The results show that the correlation coefficient R 2 =0.9962, indicating that the established regression equation has a high degree of feasibility and can well predict the yield of WSP-TCA. A-extraction temperature, C-extraction pH, interaction term AC and three square terms (A 2 , B 2 , C 2 ) has a very significant effect on WSP-TCA, while the interaction terms AB and BC have a significant effect on the WSP-TCA yield, while the other terms are not significant.

[0108] The results of variance analysis show that the influence of various factors on the yield of Spirulina polysaccharides is as follows: extraction temperature > extraction pH > extraction time. Figure 4 It can be seen that when the same extraction temperature is maintained, the yield of WSP-TCA increases rapidly with the increase of the pH of the alkali solution; as the concentration of sodium hydroxide continues to increase, the yield tends to decrease. Figure 5 It shows that the WSP-TCA yield changes with the extraction pH and extraction temperature. Figure 6 The results show that the yield of WSP-TCA changes with temperature and time. The optimal parameters of WSP-TCA extraction process are as follows: extraction temperature is 81.61℃, extraction time is 3.993h, pH is 10.146, and the yield of polysaccharide is 7.18% under these conditions.

[0109] Table 3 Analysis of variance and significance test of regression coefficients in response surface design experiments

[0110]

[0111] Based on the above, the optimal parameters of WSP-TCA extraction process were obtained, and these parameters were optimized in practice, such as 82°C, extraction time 4h, pH 10.1. Three groups of experiments were carried out, and the average yield of Spirulina polysaccharides was 7.17%, which was consistent with the calculation results of the mathematical model, indicating that the established mathematical model can well predict the polysaccharide yield.

[0112] Example 8 Structural Characterization of Soluble Polysaccharides from Spirulina Platensis

[0113] Monosaccharide composition determination

[0114] (1) Preparation of standard solution: 100 mg of each of the 13 prepared monosaccharide standards was placed in a 100 mL volumetric flask, and an appropriate amount of water was added to dissolve the solution. The volume was adjusted to the mark to prepare a standard stock solution with a mass concentration of 1000 mg / L, and stored in a refrigerator at 4°C for later use. Take out the 1000 mg / L standard stock solution and dilute it into a standard working solution with a mass concentration ranging from 0.2 to 5 mg / L.

[0115] (2) Preparation of eluent: Prepare 0.1 mol / L NaOH solution, filter deionized water using a 0.22 μm nylon filter membrane, add 994.8 mL of the treated water to a 2 L mobile phase bottle, then add 5.2 mL of 50% NaOH solution, connect to N2 gas protection and shake thoroughly for later use.

[0116] (3) Chromatographic conditions: Take out Dionex TM CarboPac TM The liquid chromatography column was of PA20 (150×3.0 mm, 10 μm) specification and the injection volume was adjusted to 5 μL. The mobile phases A, B and C were set to H2O, 0.1M NaOH, 0.1MNaOH, and 0.2MNaAc respectively, and the flow rate was set to 0.5mL / min; the column temperature was adjusted to 30℃; the elution gradient was set according to the following procedure: 0minA phase / B phase / C phase (95:5:0, V / V), 26minA phase / B phase / C phase (85:5:10, V / V), 42minA phase / B phase / C phase (85:5:10, V / V), 42.1minA phase / B phase / C phase (60:0:40, V / V), 52minA phase / B phase / C phase (60:40:0, V / V), 52.1minA phase / B phase / C phase (95:5:0, V / V), 60minA phase / B phase / C phase (95:5:0, V / V).

[0117] (4) Treatment method: First, prepare a clean chromatographic bottle, then take an appropriate amount of the soluble polysaccharide (WSP-TCA) sample of Spirulina platensis extracted in Example 1 and put it into the bottle, add 1 mL of a 2M trifluoroacetic acid solution, and then heat the reaction at 121°C for 2 hours. Then, introduce nitrogen gas to dry the sample. Then, wash it with 99.99% methanol, dry it again, and repeat the methanol washing 2-3 times. After that, add sterile water to dissolve the sample and transfer it to a chromatographic bottle for ion chromatography analysis.

[0118] The monosaccharide composition of WSP-TCA was analyzed by ion chromatography, and the peak order of the monosaccharide composition in WSP-TCA was determined by the peak period of the monosaccharide standard: fucose (Fuc), rhamnose (Rha), arabinose (Ara), galacturonic acid (GalA), glucose (Glc), and mannose (Man). Figure 7 The results showed that WSP-TCA was mainly composed of glucose, rhamnose and fucose with a molar ratio of 37.37:32.50:5.76. In addition, it also contained a small amount of arabinose and glucuronic acid.

[0119] Relative molecular weight determination

[0120] High performance gel permeation chromatography (HPGPC) was used to determine the relative molecular weight of WSP-TCA extracted in Example 1. The equipment used in the experiment included a chromatograph, used together with a differential refractometer, 0.1 mol / L sodium nitrate solution as the mobile phase, the flow rate was set at 0.9 mL / min, and the experiment was carried out at a column temperature of 45°C.

[0121] The relative molecular weight of WSP-TCA was measured by GPC. Figure 8 As shown. There is only one symmetrical peak observed in the WSP-TCA spectrum, which can prove that WSP-TCA has a single component and a relatively concentrated molecular weight. The polymer dispersibility index (PDI) of WSP-TCA measured by GPC method is 2.23, indicating that the molecular weight distribution of WSP-TCA is uniform, further confirming that WSP-TCA is a homogeneous polysaccharide. Using a dextran standard with a known molecular weight as a control, the weight average molecular weight (Mw) and number average molecular weight (Mn) of WSP-TCA were measured to be 219851Da and 98572Da, respectively, indicating that WSP-TCA is a high molecular weight polysaccharide.

[0122] Infrared spectroscopy

[0123] For the infrared spectrum analysis of WSP-TCA, the potassium bromide tablet method was used in this experiment. 1 mg of WSP-TCA was placed in a mortar, and an appropriate amount of dry KBr was added. The powder was fully ground under infrared light to obtain a powdery substance. The processed powder was placed on a tablet press and pressed into a transparent film as thin as 1 mm and 10 mm in diameter. The thin film was then analyzed using a Fourier transform infrared spectrometer at 400-4000 cm -1 Scan within range.

[0124] Infrared spectroscopy was used to identify the functional group composition of WSP-TCA. Fig. 9 As shown in the figure, the infrared spectrum of WSP-TCA shows the characteristic absorption peak of polysaccharide. -1The absorption peak at 2931cm indicates that the polysaccharide contains OH bonds, and the shape is wide and blunt, indicating that the hydroxyl groups are bound inside the molecule rather than in a free state; -1 The presence of absorption peaks indicates that WSP-TCA contains -CH2- groups; -1 The absorption peak at 1536 cm -1 The absorption peak at 1400-1200 cm -1 The absorption peak is caused by the stretching vibration and angle change of the CH bond in WSP-TCA; 1300-1000cm -1 The absorption peak at indicates that WSP-TCA contains a pyran ring structure.

[0125] Nuclear magnetic resonance measurement

[0126] The WSP-TCA sample was first dissolved in 1.00 mL of heavy water, then allowed to stand overnight, freeze-dried using a freeze dryer, and then 1.00 mL of heavy water was added. The above steps were repeated three times to obtain a freeze-dried WSP-TCA sample, which was dissolved in 0.80 mL of heavy water and loaded into a nuclear magnetic resonance tube using a syringe for hydrogen spectrum measurement.

[0127] use 1 H-NMR further confirmed the type of WSP-TCA glycosidic bond. Fig.10 It can be found that there are multiple anomeric hydrogen signals of sugars in the 4.3-5.5ppm anomeric region; the signals in the range of 3.22-4.18ppm are attributed to the connecting protons of the residual sugar C2-C6 of the polysaccharide, and it is speculated that the multiple peaks at the 2.03ppm position are attributed to the methyl-CH3 protons of the residual sugar, which indicates that methyl pentoses such as rhamnose may exist in the monosaccharide composition, which is consistent with the results of the monosaccharide composition determination. Analysis of the anomeric region shows that: 5.24ppm and 4.40ppm are two relatively obvious absorption signals, which are respectively attributed to α and β configurations, confirming that the two configurations of residual sugars at these two locations constitute the main part of the polysaccharide; at the same time, after carefully distinguishing the multiple weak signals in the anomeric region, it is speculated that the polysaccharide is composed of 6-10 monosaccharides, which is consistent with the results of the monosaccharide determination.

[0128] Example 9 Determination of the in vitro antioxidant activity of soluble polysaccharides from Spirulina platensis

[0129] (1) DPPH free radical scavenging ability determination method

[0130] The soluble polysaccharide (WSP-TCA) of Spirulina platensis obtained by extraction in Example 1 was mixed with purified water to prepare solutions of different concentrations of 0.05, 0.2, 0.5, 1.0, and 2.0 mg / mL, and anhydrous alcohol and DPPH were used to prepare a 0.2 mmol / L DPPH solution. 1.0 mL of polysaccharide and 1.0 mL of DPPH solution were added to 5 test tubes, mixed, and placed in a dark room for 30 min. When the reaction was completed, the absorbance A at 517 nm was measured. Three groups of biological replicates were designed for each sample, and the clearance rate of cell wall polysaccharide of Spirulina platensis was calculated according to the following formula:

[0131] Clearance rate (%) = A0-(A1-A2) / A0×100%;

[0132] In the formula: A0—purified water + DPPH solution; A1—polysaccharide solution + DPPH solution; A2—polysaccharide solution + purified water.

[0133] The scavenging ability of soluble polysaccharides of Spirulina platensis (WSP-TCA) at different concentrations on DPPH free radicals was shown in Figure 2. Fig.11 As shown in the figure, in the range of 0 mg / mL-5.0 mg / mL, WSP-TCA has the ability to scavenge DPPH free radicals. When the concentration reaches 5 mg / mL, the scavenging rate of WSP-TCA is (71.77±1.03)%, indicating that CWSP has a high scavenging ability for DPPH free radicals.

[0134] (2) Hydroxyl radical scavenging ability determination method

[0135] The soluble polysaccharide (WSP-TCA) of Spirulina platensis obtained by extraction in Example 1 was prepared into solutions with purified water at different concentrations of 0.05, 0.2, 0.5, 1.0, 2.0, 3.0, 4.0 and 5.0 mg / mL. Eight test tubes were taken and 1 mL of the above-mentioned cell wall polysaccharide solutions of Spirulina platensis with different concentrations, as well as 1 mL of 6 mmol / L FeSO4 solution, 6 mmol / L salicylic acid solution and 6 mmol / L H2O2 solution were added respectively. After mixing, the mixture was placed in a dark cabinet to react for 10 min. After the reaction was completed, the absorbance A value was measured at 510 nm, with purified water as blank and ascorbic acid as positive control. Three groups of biological replicates were designed for each sample. The clearance rate of the cell wall polysaccharide solution of Spirulina platensis was calculated according to the following formula:

[0136] Clearance rate (%) = A0-(A1-A2) / A0×100%;

[0137] In the formula: A0—FeSO4+salicylic acid+H2O2 solution; A1—FeSO4+salicylic acid+H2O2+polysaccharide solution; A2—FeSO4+salicylic acid+polysaccharide solution.

[0138] The scavenging ability of different concentrations of Spirulina platensis soluble polysaccharide (WSP-TCA) on hydroxyl radicals Fig.12 As shown, within the concentration range of 0 mg / mL-5.0 mg / mL, with the increase of concentration, the WSP-TCA clearance rate showed an upward trend. When the concentration was 5 mg / mL, the WSP-TCA clearance rate was (58.10±2.45)%, indicating that WSP-TCA also has the ability to scavenge hydroxyl radicals.

[0139] (3) Total reducing power determination method

[0140] The soluble polysaccharide (WSP-TCA) of Spirulina platensis obtained by extraction in Example 1 was mixed with purified water to prepare solutions of different concentrations of 0.05, 0.2, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, and 6.0 mg / mL. The phosphate buffer solution and potassium ferricyanide solution were prepared in advance. Nine test tubes were prepared, and 2.0 mL of the above WSP-TCA solution was transferred to each test tube. Then, 2.5 mL of phosphate buffer and potassium ferricyanide solution were added to each test tube. After stirring evenly with a vortex oscillator, the test tube was placed in 50°C water and heated. After 20 minutes, 2.5 mL of 10% trichloroacetic acid solution was added to each tube and centrifuged for 8 minutes. 2.5 mL of liquid was extracted from the top of the centrifuge tube with a pipette, and then purified water and ferric chloride solution were added in sequence. The absorbance at 700 nm was measured, and three groups of biological replicates were designed for each sample.

[0141] Total reducing power of different concentrations of soluble polysaccharide from Spirulina platensis (WSP-TCA) Fig.13 As shown, in the range of 0 mg / mL-5.0 mg / mL, with the increase of concentration, the scavenging effect gradually improved. When the concentration was 5 mg / mL, the absorbance of WSP-TCA at 700 nm was (1.00±0.11), indicating that the cell wall polysaccharide of Spirulina platensis has a strong reducing power.

[0142] The present invention determines the in vitro antioxidant activity of the soluble polysaccharide (WSP-TCA) of Spirulina platensis, and finds that WSP-TCA can effectively remove DPPH free radicals and hydroxyl free radicals, and has a strong total reducing power, indicating that the WSP-TCA obtained by the extraction process of the present invention has potential application value in antioxidants or antioxidant drugs.

[0143] Example 10 Study on the anti-tumor activity of soluble polysaccharides from Spirulina platensis in cell models

[0144] Effects of soluble polysaccharide from Spirulina platensis (WSP-TCA) on the viability of different types of tumor cells

[0145] 4T1, HeLa, and HCT116 were used as experimental cells, and the CCK-8 cell viability assay was used to determine the toxic effects of the soluble polysaccharide (WSP-TCA) extracted from Spirulina platensis in Example 1 on the above three cells at different concentrations. In the experiment, nine concentration gradients of WSP-TCA, 0, 5, 10, 20, 40, 80, 100, 200 and 500 μg / mL, were selected to act on the cells.

[0146] The cytotoxic effects of WSP-TCA on 4T1, HeLa and HCT116 cells Figure 14-16 As shown, it can be seen that with the increase of polysaccharide concentration, the cell viability of 4T1, HeLa, and HCT116 cells is inhibited to varying degrees, and the inhibitory effect shows a positive growth relationship with the dose of WSP-TCA. At the highest dosage concentration (500 μg / mL), WSP-TCA has the highest inhibition rate on 4T1 cell proliferation, and the cell viability is 47.82%. The results show that WSP-TCA can inhibit the growth of various tumor cells and produce cytotoxicity.

[0147] Effects of WSP-TCA on the viability of normal cells

[0148] In order to verify that the toxic effect of WSP-TCA on tumor cells is based on its anti-tumor activity rather than the toxicity of the polysaccharide itself, human umbilical vein endothelial cells (HUVEC) were selected to evaluate the effect of polysaccharides on the viability of normal cells in the body and verify the safety of polysaccharide drugs. Fig.17 As shown, WSP-TCA has no significant toxicity to the proliferation of normal cells within the experimental concentration range (0-500 μg / mL), and even has the effect of promoting cell proliferation at high concentrations. It is speculated that this is because WSP-TCA, as a functional nutrient, promotes cell growth.

[0149] Cell scratch assay to detect the effect of WSP-TCA on tumor cell migration ability

[0150] The cell scratch assay was used to detect the effect of WSP-TCA on the migration ability of tumor cells. Fig.18 As shown, WSP-TCA has a certain inhibitory effect on the migration ability of 4T1 and HeLa cells, and this inhibitory effect is positively proportional to the concentration of WSP-TCA. Fig.19 The effect of WSP-TCA on the wound healing rate of 4T1 cells is shown. After 10 hours of scratching, the wound healing percentages of the control group and the 200 μg / mL concentration WSP-TCA group were 38.14% and 4.73%, respectively. The wound healing rate decreased by 33.41% after WSP-TCA treatment, which was significantly different (p<0.05), indicating that WSP-TCA can significantly inhibit the migration ability of 4T1 cells. Fig. 20The effect of WSP-TCA on the wound healing rate of HeLa cells is shown. 24 hours after scratching, the wound healing percentages of the control group and the 200 μg / mL WSP-TCA group were 50.67% and 7.93%, respectively, with significant differences (p<0.05), indicating that WSP-TCA has a good ability to inhibit the migration of HeLa cells.

[0151] Effects of WSP-TCA on the production of reactive oxygen species in 4T1 cells

[0152] DCFH-DA fluorescent probe was used to detect the total intracellular ROS level to explore the effect of WSP-TCA on the generation of reactive oxygen species in tumor cells. Fig.21 As shown, with the extension of WSP-TCA action time and the increase of concentration, the fluorescence became more and more obvious, indicating that WSP-TCA can increase the level of ROS in 4T1 cells in a dose-dependent manner, which may be one of the pathways for WSP-TCA to induce 4T1 cell apoptosis.

[0153] Effects of WSP-TCA on the production of reactive oxygen species in HUVEC cells

[0154] like Fig. 22 As shown in the figure, in normal cells, WSP-TCA eliminates ROS in HUVEC cells in a dose-dependent manner, indicating that the promotion effect of WSP-TCA on the level of ROS in 4T1 cells is specific, which may be one of the pathways for WSP-TCA to induce apoptosis of 4T1 cells. In normal somatic cells, the cell activity state is maintained by inhibiting the expression of ROS. Therefore, without disrupting other normal physiological processes of the body, the application of natural drugs that can scavenge reactive oxygen free radicals can delay cell aging and maintain the body's stable state.

[0155] Example 11 Study on the anti-tumor activity of soluble polysaccharides from Spirulina platensis in animal models

[0156] Effects of soluble polysaccharide from Spirulina platensis (WSP-TCA) on body weight and behavioral status of tumor-bearing mice

[0157] All experimental operations followed the relevant policies and guidelines of the Animal Safety and Regulation Management Office of Beijing Forestry University. After 3 days of adaptive culture, 4-week-old pathogen-free (SPF) female babl / c mice were randomly divided into 2 groups. 4T1 cells in the logarithmic growth phase were taken and inoculated subcutaneously in the right hind leg. On the 4th day after inoculation, the solid tumor began to have obvious protrusions, indicating that the inoculation was successful. When the tumor volume reached 75mm 3At 3 pm, recorded as day 0, the mice in the experimental group were injected with the soluble polysaccharide (WSP-TCA) extracted from Spirulina platensis in Example 1 at a concentration of 50 mg / kg through the tail vein, and the mice in the control group were given the same dose of PBS. The drugs were administered three times in total, and the mice were dissected on the 14th day.

[0158] The toxicity and side effects of WSP-TCA on mice were evaluated by recording the weight of mice. Fig.23 The weight changes of 4T1 tumor-bearing mice in the control group and the experimental group can be seen. As time went on, the weight of 4T1 tumor-bearing mice in the control group and the experimental group showed an increasing trend. From day 7 to day 14, the tumor tissue of the mice in the control group grew rapidly, and the volume and weight of the tumor mass increased. The weight of the control mice was higher than that of the experimental group. The differences in the 6 weighing results were not significant, indicating that WSP-TCA has biosafety.

[0159] By observing the behavioral status of mice in the control group and the experimental group, it was found that the behavioral performance of the two groups of mice was normal on days 0-3; on days 4-7, the mice in the control group had rough fur and slightly depressed spirits, while the mice in the experimental group had good mental and dietary status; on days 7-14, the mice in the control group had larger tumor tissues, sparse fur, poor appetite, and rapid breathing. Fig.23 It can be seen that the weight gain slowed down significantly from day 12 to day 14. Compared with the control group, the mice in the WSP-TCA group had smooth fur, good mental and dietary status, and small weight changes, with no significant difference (P>0.05).

[0160] Determination of the inhibition rate of WSP-TCA on solid tumors in tumor-bearing mice

[0161] Fig.24 The figure shows the in vitro morphology of tumor tissue in 4T1 tumor-bearing mice on day 14. The tumor volume of the control group mice was larger than that of the experimental group mice, and there was no ulceration of the solid tumors in all mice. Fig.25 It can be seen that there was no significant difference in the volume of solid tumors between the two groups of mice on day 0 (P>0.05); from day 0 to day 14, the volume of solid tumors in the control group was larger and grew faster. In comparison, the tumor growth of mice in the experimental group was significantly inhibited (p<0.05); on day 14, the tumor volume growth inhibition rate of mice in the experimental group was 68%. WSP-TCA can significantly inhibit the growth of tumors in 4T1 tumor-bearing mice in vivo.

[0162] Effects of WSP-TCA on immune organ indexes in tumor-bearing mice

[0163] The effect of WSP-TCA on the immune function of mice was evaluated by the spleen index. The spleens of the two groups of mice were taken, the connective tissue was removed, and the index of each organ was weighed. The spleens of the mice in the control group were dark red and swollen, indicating that the massive proliferation of tumors triggered an inflammatory response, resulting in damage to the immune system. Table 4 shows the spleen index of the two groups of mice. It can be inferred that the tumor cells caused strong immune damage in the body, resulting in hyposplenism in the mice in the control group. Compared with the spleen index of the control group mice, the spleen index of the mice treated with WSP-TCA was significantly reduced (p<0.05), indicating that WSP-TCA not only has anti-tumor activity, but also can reduce the damage of the unlimited proliferation of tumors to the immune tissues of normal mice, thereby exerting its good immune function, *p<0.05.

[0164] Table 4 Results of spleen index of mice in each group

[0165] Group Spleen index Control group 3.23±0.37 Experimental Group 4.78±0.31*

[0166] Effect of WSP-TCA on tumor histopathology in tumor-bearing mice

[0167] The tumor cells in tumor-bearing mice were pathologically examined by H&E method. Fig.26 As shown in the figure, the tumor cells in the control group were large, neatly arranged, well-structured, with dark nuclear staining, less intercellular matrix and cytoplasm, and almost no necrotic cells were observed, indicating that the tumor cells in the mice in the control group grew normally and the tumor-bearing mouse model was successfully established. In contrast, the tumor cells were significantly smaller, the structure of the tumor cells was broken, the number of cells decreased, and the arrangement was loose. The above results show that WSP-TCA has a significant anti-tumor effect.

[0168] Effects of WSP-TCA on spleen histopathology in tumor-bearing mice

[0169] Fig. 27 These are H&E sections of spleen tissue from 4T1 tumor-bearing mice in the control and experimental groups. The spleen of mice in the control group showed swelling, loose structure, blurred boundaries, and difficulty in observation. At the same time, the white pulp rate in the bone marrow was significantly reduced. Compared with the control group, after treatment with WSP-TCA, the percentage of white pulp in the spleen of mice increased significantly, the cell structure of the spleen was more regular, and the boundary between the red and white bone marrow could be clearly seen. This result is consistent with the fact that WSP-TCA treatment can increase the spleen index of 4T1 tumor-bearing mice and increase the number of white blood cells and lymphocytes in mice, indicating that WSP-TCA treatment can significantly improve the immune system of 4T1 tumor-bearing mice.

[0170] Effects of WSP-TCA on histopathology of organs in tumor-bearing mice

[0171] Depend on Figure 28-31It can be seen that myocardial fibers were regularly distributed and morphologically normal in all model mice. The liver cells in the control group were scattered and disorderly arranged. In sharp contrast, after treatment with WSP-TCA, the liver tissue morphology of the mice in the experimental group was better, with regular arrangement, more cytoplasm, and obvious nuclei. The lung tissue sections of all model mice showed a honeycomb structure, and no inflammatory cell infiltration was observed. The kidney cells of the mice in the control group were disorderly arranged, and the glomeruli became smaller; compared with the control group, the glomeruli of the mice in the experimental group were more intact and had better cell distribution.

[0172] The above results show that WSP-TCA has good biosafety and has potential application in anti-tumor drugs.

[0173] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for extracting soluble polysaccharides from Spirulina platensis, It is characterized in that The steps include: The Spirulina platensis powder is subjected to hot alkali extraction to obtain an extract; The extract is centrifuged to collect the supernatant and the precipitate; the precipitate is subjected to hot alkali leaching and centrifugation again to obtain the supernatant, and the supernatants are combined to obtain the platensis liquid; Add 25% trichloroacetic acid to the above Spirulina platensis solution for deproteinization and then dialyze to obtain a dialysate; The dialyzate is subjected to alcohol precipitation and freeze-drying to obtain the soluble polysaccharide of Spirulina platensis.

2. The extraction method according to claim 1, It is characterized in that The conditions for the hot alkali leaching are to adjust the solution pH to 10-10.5 and heat the solution in a water bath at 80-90° C. for 3.5-4.5 hours.

3. The extraction method according to claim 1, It is characterized in that The centrifugal condition is 4000-6000 r / min for 10-20 min.

4. The extraction method according to claim 1, It is characterized in that The volume mass ratio of the 25% trichloroacetic acid to the Spirulina platensis powder is 0.5-0.8:

1.

5. The extraction method according to claim 1, It is characterized in that The dialysis condition is to use a dialysis bag with a pore size of 3kD-4kD for 40-50h.

6. The extraction method according to claim 1, It is characterized in that The ethanol concentration of the alcohol precipitation is 90-95%.

7. The soluble polysaccharide of Spirulina platensis obtained by the extraction method according to any one of claims 1 to 6.

8. Use of the soluble polysaccharide of Spirulina platensis according to claim 7 in the preparation of antioxidants.

9. Use of the soluble polysaccharide of Spirulina platensis according to claim 7 in the preparation of anti-tumor drugs.

10. The use according to claim 9, It is characterized in that The tumor includes one of breast cancer, cervical cancer or colon cancer.

Citation Information

Cited By

  • Spirulina alpha-glucan containing soluble dietary fibers and having immunomodulatory activity and preparation method thereof

    CN119614652A